CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 200 shares at $41.00 ($8,200)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 200 shares at $40.00 ($8,000)
- 4 Planned sale Chief Financial Officer sold 3,651 shares at $36.77 ($134,247)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 8,546 shares at $36.87 ($315,091)
- 4 Planned sale Director sold 200 shares at $40.00 ($8,000)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Option exercise Director acquired 2,302 shares (option exercise)
- 4 Planned sale Chief Executive Officer sold 11,085 shares at $36.67 ($406,487)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 1,400 shares at $40.00 ($56,000)
Page 6 of 66 · 1,304 filings